The prices below come from a named provider’s published offers. They are not a market-wide range or an individual vaccination recommendation.
Named self-pay prices per dose
Checked 17 October 2026: Dedicare lists Arexvy at HK$1,980 per dose. Its page states no additional consultation or injection fee; confirm current offer conditions and supply before booking.
Checked the same day: Dedicare lists Abrysvo at HK$2,080 per dose, with no additional consultation or injection fee stated. Confirm offer conditions and supply.
Is a subsidy available?
The inspected CHP VSS page lists influenza and pneumococcal vaccines, not RSV. This does not establish every insurer’s, employer’s or other funding arrangement. Confirm your own route and provider; do not deduct a subsidy from a self-pay offer yourself.
What else should I check?
A registration record or offer page does not replace the product’s current local indications. Ask a doctor to check the exact product, age and health, pregnancy considerations, applicable dosing and individual benefits and risks; then confirm the total fee and supply with the provider.